Neothera Research Private Limited is dedicated to unlocking the transformative potential of phyto therapeutics. Through rigorous research initiatives, we aim to leverage the diverse bioactive compounds found in nature to address unmet medical needs and develop effective therapeutic solutions. Neothera Research has developed a groundbreaking phyto-active principle-based formulation that has shown excellent results in preclinical studies of demyelination. This formulation leverages the power of Phyto molecules (secondary metabolize ) to address, not just the symptoms but the underlying causes of demyelinating diseases, like multiple sclerosis.